ELK1 and central nervous system cancer: Inhibition of ELK1 activity had also been mentioned in Human bronchial epithelial (HBE) cells [327]; however, this was the first mention of ELK1 inhibition by PI3K-AKT inhibition in gliomas/glioblastomas.